• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

68Ga-前列腺特异性膜抗原-HBED-CC早期动态正电子发射断层扫描/计算机断层扫描在前列腺腺癌患者中的作用:初步结果

Role of Early Dynamic Positron Emission Tomography/Computed Tomography with 68Ga-prostate-specific Membrane Antigen-HBED-CC in Patients with Adenocarcinoma Prostate: Initial Results.

作者信息

Perveen Gazala, Arora Geetanjali, Damle Nishikant Avinash, Prabhu Meghana, Arora Saurabh, Tripathi Madhavi, Bal Chandrasekhar, Kumar Praveen, Kumar Rajeev, Singh Prabhjot

机构信息

Department of Nuclear Medicine, AIIMS, New Delhi, India.

Department of Urology, AIIMS, New Delhi, India.

出版信息

Indian J Nucl Med. 2018 Apr-Jun;33(2):112-117. doi: 10.4103/ijnm.IJNM_8_18.

DOI:10.4103/ijnm.IJNM_8_18
PMID:29643670
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5883427/
Abstract

RATIONALE

Prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) is widely used for imaging of prostate cancer (PC) nowadays. However, appearance of bladder activity many a times hampers lesion detection vis-a-vis primary as well as regional nodes. We aimed to assess if early dynamic PET/CT can be a potential solution to this issue.

METHODOLOGY

A total of 15 biopsy-proven PC patients who were referred to our department for Ga-PSMA PET/CT for staging/restaging were prospectively studied. Dynamic PET/CT was done with on table intravenous injection of 2-3 mCi (74-111 MBq) of the radiotracer. Dynamic images were acquired over the pelvis with a frame time of 1 min for 10 min. Static images of 2 min per bed position were acquired between 45 and 60 min after injection. A 3D volume of interest was plotted on the primary lesion, involved nodes if any, pelvic bones at involved and uninvolved sites, gluteal muscles, and bladder.

RESULTS

Six patients were referred for staging and 9 for restaging. Mean age of 15 patients was 66.7 years, median prostate-specific antigen level was 17.25 ng/ml (Range 0.05-218), mean Gleason score was 8. All patients showed high target to nontarget ratio in the early dynamic images comparable to that seen on the delayed images in different sites (prostatic primary: = 15 patients; lymph nodes: = 10 patients; bone: = 5 patients). All pathologic lesions showed tracer uptake within the first 3 min and reached maximum uptake during the dynamic study in last 3 min, indicating an increasing uptake pattern, whereas urinary bladder (UB) activity was insignificant within the first 3 min of dynamic imaging in all patients, reached maximum during last 3 min. SUV was significantly higher in primary lesions in the first 4 min compared to UB accumulation. Static images showed more tracer accumulation than dynamic images in primary, nodal, and bony lesions. However, all regional nodes seen on delayed static imaging also showed uptake on dynamic imaging.

CONCLUSION

Early dynamic imaging Ga-PSMA PET/CT can demarcate the primary tumor clearly due to nonaccumulation of bladder activity and appears to have comparable efficacy in detecting pelvic nodal sites as delayed imaging.

摘要

原理

前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描(PSMA PET/CT)如今广泛用于前列腺癌(PC)的成像。然而,膀胱活动的出现多次妨碍了对原发灶以及区域淋巴结病变的检测。我们旨在评估早期动态PET/CT是否可能是解决此问题的潜在方法。

方法

前瞻性研究了总共15例经活检证实为PC的患者,他们因Ga-PSMA PET/CT分期/再分期而转诊至我们科室。在检查台上静脉注射2 - 3毫居里(74 - 111兆贝可)放射性示踪剂后进行动态PET/CT检查。在骨盆区域采集动态图像,帧时间为1分钟,共采集10分钟。在注射后45至60分钟之间,每个床位采集2分钟的静态图像。在原发灶、如有受累的淋巴结、受累和未受累部位的骨盆骨、臀肌以及膀胱上绘制三维感兴趣区。

结果

6例患者转诊进行分期,9例进行再分期。15例患者的平均年龄为66.7岁,前列腺特异性抗原水平中位数为17.25纳克/毫升(范围0.05 - 218),平均 Gleason评分8分。所有患者在早期动态图像中显示出高的靶与非靶比值,与不同部位延迟图像中的情况相当(前列腺原发灶:n = 15例患者;淋巴结:n = 10例患者;骨:n = 5例患者)。所有病理性病变在最初3分钟内显示示踪剂摄取,并在动态研究的最后3分钟达到最大摄取,表明摄取模式呈增加趋势,而在所有患者动态成像的最初3分钟内膀胱(UB)活动不明显,在最后3分钟达到最大值。与UB积聚相比,原发灶在最初4分钟内的SUV显著更高。静态图像在原发灶、淋巴结和骨病变中显示出比动态图像更多的示踪剂积聚。然而,延迟静态成像中看到的所有区域淋巴结在动态成像中也显示有摄取。

结论

早期动态成像的Ga-PSMA PET/CT由于膀胱无活动积聚可清晰界定原发肿瘤,并且在检测盆腔淋巴结部位方面似乎与延迟成像具有相当的效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bf0/5883427/c49f13c7a76f/IJNM-33-112-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bf0/5883427/7622c213c46e/IJNM-33-112-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bf0/5883427/1402a500ce4f/IJNM-33-112-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bf0/5883427/f3670a4ec7a5/IJNM-33-112-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bf0/5883427/c49f13c7a76f/IJNM-33-112-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bf0/5883427/7622c213c46e/IJNM-33-112-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bf0/5883427/1402a500ce4f/IJNM-33-112-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bf0/5883427/f3670a4ec7a5/IJNM-33-112-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bf0/5883427/c49f13c7a76f/IJNM-33-112-g007.jpg

相似文献

1
Role of Early Dynamic Positron Emission Tomography/Computed Tomography with 68Ga-prostate-specific Membrane Antigen-HBED-CC in Patients with Adenocarcinoma Prostate: Initial Results.68Ga-前列腺特异性膜抗原-HBED-CC早期动态正电子发射断层扫描/计算机断层扫描在前列腺腺癌患者中的作用:初步结果
Indian J Nucl Med. 2018 Apr-Jun;33(2):112-117. doi: 10.4103/ijnm.IJNM_8_18.
2
Can Early Dynamic Positron Emission Tomography/Computed Tomography Obviate the Need for Postdiuresis Image in Ga-PSMA-HBED-CC Scan for Evaluation of Prostate Adenocarcinoma?早期动态正电子发射断层扫描/计算机断层扫描能否避免在用于评估前列腺腺癌的镓-PSMA-HBED-CC扫描中进行利尿后成像的必要性?
Indian J Nucl Med. 2018 Jul-Sep;33(3):202-208. doi: 10.4103/ijnm.IJNM_32_18.
3
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
4
Early dynamic imaging in Ga- PSMA-11 PET/CT allows discrimination of urinary bladder activity and prostate cancer lesions.镓-PSMA-11正电子发射断层显像/计算机断层扫描(PET/CT)中的早期动态成像能够区分膀胱活动和前列腺癌病灶。
Eur J Nucl Med Mol Imaging. 2017 May;44(5):765-775. doi: 10.1007/s00259-016-3578-z. Epub 2016 Nov 29.
5
Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence.使用[68]Ga-PSMA-11进行早期PET成像可提高生化复发的前列腺癌患者局部复发的检出率。
Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1647-1655. doi: 10.1007/s00259-017-3743-z. Epub 2017 Jun 6.
6
Ga-Labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography for Prostate Cancer: A Systematic Review and Meta-analysis.Ga 标记前列腺特异性膜抗原配体正电子发射断层扫描/计算机断层扫描在前列腺癌中的应用:系统评价和荟萃分析。
Eur Urol Focus. 2018 Sep;4(5):686-693. doi: 10.1016/j.euf.2016.11.002. Epub 2016 Nov 15.
7
Efficacy of early imaging with Ga-PSMA-I&T in the discrimination of pelvic lesions in prostate cancer patients.Ga-PSMA-I&T早期成像在鉴别前列腺癌患者盆腔病变中的疗效
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2019 Mar-Apr;38(2):100-105. doi: 10.1016/j.remn.2018.06.006. Epub 2018 Dec 1.
8
Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour.镓-PSMA-11 PET/CT在前列腺癌初始分期中的应用:前列腺特异抗原(PSA)和 Gleason评分可预测原发肿瘤中示踪剂摄取强度。
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):941-949. doi: 10.1007/s00259-017-3631-6. Epub 2017 Jan 31.
9
Evaluation of PSMA PET/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging.使用68Ga-HBED-CC配体对前列腺癌患者进行PSMA PET/CT成像评估及早期盆腔成像的价值
Nucl Med Commun. 2015 Jun;36(6):582-7. doi: 10.1097/MNM.0000000000000290.
10
Impact of uptake time on image quality of [ Ga]Ga-PSMA-11 PET/CT.[Ga]Ga-PSMA-11 PET/CT 摄取时间对图像质量的影响。
Med Phys. 2023 Dec;50(12):7619-7628. doi: 10.1002/mp.16429. Epub 2023 Apr 24.

引用本文的文献

1
The future of PSMA PET and WB MRI as next-generation imaging tools in prostate cancer.PSMA PET 和 WB MRI 作为前列腺癌下一代成像工具的未来。
Nat Rev Urol. 2022 Aug;19(8):475-493. doi: 10.1038/s41585-022-00618-w. Epub 2022 Jul 4.
2
Diagnostic performance of Gallium-68 prostate-specific membrane antigen positron emission tomography-computed tomography in intermediate and high risk prostate cancer.镓-68前列腺特异性膜抗原正电子发射断层扫描-计算机断层扫描在中高危前列腺癌中的诊断效能
Medicine (Baltimore). 2019 Nov;98(44):e17491. doi: 10.1097/MD.0000000000017491.
3
Can Early Dynamic Positron Emission Tomography/Computed Tomography Obviate the Need for Postdiuresis Image in Ga-PSMA-HBED-CC Scan for Evaluation of Prostate Adenocarcinoma?

本文引用的文献

1
Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence.使用[68]Ga-PSMA-11进行早期PET成像可提高生化复发的前列腺癌患者局部复发的检出率。
Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1647-1655. doi: 10.1007/s00259-017-3743-z. Epub 2017 Jun 6.
2
Multiple Time-Point 68Ga-PSMA I&T PET/CT for Characterization of Primary Prostate Cancer: Value of Early Dynamic and Delayed Imaging.多时间点 68Ga-PSMA I&T PET/CT 用于原发性前列腺癌的特征分析:早期动态和延迟成像的价值。
Clin Nucl Med. 2017 Jun;42(6):e286-e293. doi: 10.1097/RLU.0000000000001589.
3
早期动态正电子发射断层扫描/计算机断层扫描能否避免在用于评估前列腺腺癌的镓-PSMA-HBED-CC扫描中进行利尿后成像的必要性?
Indian J Nucl Med. 2018 Jul-Sep;33(3):202-208. doi: 10.4103/ijnm.IJNM_32_18.
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer.
EAU-ESTRO-SIOG 前列腺癌诊治指南。第二部分:复发、转移和去势抵抗性前列腺癌的治疗。
Eur Urol. 2017 Apr;71(4):630-642. doi: 10.1016/j.eururo.2016.08.002. Epub 2016 Aug 31.
4
Normal distribution pattern and physiological variants of 68Ga-PSMA-11 PET/CT imaging.68Ga-PSMA-11 PET/CT成像的正态分布模式及生理变异
Nucl Med Commun. 2016 Nov;37(11):1169-79. doi: 10.1097/MNM.0000000000000566.
5
(68)Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report.前列腺癌患者的(68)Ga-PSMA配体PET/CT:我们的评估与报告方式
Cancer Imaging. 2016 Jun 8;16(1):14. doi: 10.1186/s40644-016-0072-6.
6
Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy.18F-氟甲基胆碱与 68Ga-PSMA PET/CT 在经治愈性治疗后 PSA 升高且正在考虑靶向治疗的前列腺癌患者中的前瞻性比较。
J Nucl Med. 2015 Aug;56(8):1185-90. doi: 10.2967/jnumed.115.160382. Epub 2015 Jun 25.
7
Evaluation of PSMA PET/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging.使用68Ga-HBED-CC配体对前列腺癌患者进行PSMA PET/CT成像评估及早期盆腔成像的价值
Nucl Med Commun. 2015 Jun;36(6):582-7. doi: 10.1097/MNM.0000000000000290.
8
Significant increase in detection of prostate cancer recurrence following radical prostatectomy with an early imaging acquisition protocol with ¹⁸F-fluorocholine positron emission tomography/computed tomography.采用¹⁸F-氟胆碱正电子发射断层扫描/计算机断层扫描早期成像采集方案,在前列腺癌根治术后检测到前列腺癌复发显著增加。
World J Urol. 2015 Oct;33(10):1511-8. doi: 10.1007/s00345-015-1481-z. Epub 2015 Jan 11.
9
Preclinical evaluation of a bispecific low-molecular heterodimer targeting both PSMA and GRPR for improved PET imaging and therapy of prostate cancer.针对 PSMA 和 GRPR 的双特异性低分子杂二聚体的临床前评估,用于改善前列腺癌的 PET 成像和治疗。
Prostate. 2014 May;74(6):659-68. doi: 10.1002/pros.22784. Epub 2014 Jan 25.
10
Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer.比较(68)Ga 标记的 PSMA 配体与基于(18)F-胆碱的 PET/CT 在诊断复发性前列腺癌中的作用。
Eur J Nucl Med Mol Imaging. 2014 Jan;41(1):11-20. doi: 10.1007/s00259-013-2525-5. Epub 2013 Sep 27.